Schedule of Roll forward of Valuation Allowance (Details) - Chemomab Therapeutics Ltd [Member] - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Valuation allowance, balance | $ 44,219 | $ 43,471 | $ 41,195 |
| Currency translation Income | (2,459) | (3,295) | |
| Increase in valuation allowance | 2,916 | 3,207 | 5,571 |
| Increase in valuation allowance for capital losses | 3,271 | ||
| Decrease in valuation allowance | (547) | ||
| Net increase during the year | 5,640 | ||
| Valuation allowance, balance | $ 49,859 | $ 44,219 | $ 43,471 |